Trial intelligence / Profile preview

Indomethacin for acute pancreatitis

ChiCTR-IPR-17012971Phase 4Recruiting

Sponsor
Peking Union Medical College Hospital
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of indomethacin in acute pancreatitis (AP) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Total effective rate of treatment, Mortality and 5 more. Started Oct 2017; status: recruiting.

02

Drugs

indomethacin
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on ChiCTR-IPR-17012971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17012971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call